And studies have shown that JAK2 inhibitor TG101209 can inhibit T cell acute lymphoblastic leukemia (T-ALL) proliferation by inhibiting JAK/STAT pathway activation and regulating the interaction between apoptosis and autophagy (Cheng et al., 2017). Here, SOAT1 is linked to acute lymphoblastic leukemia.